Stefano Bertolini graduated with full marks in medicine in 1967. He is specialized in endocrinology in 1969. He worked as a research fellow from 1968 to 1969, an assistant professor of medicine from 1970 to 1980, an associate professor of clinical nutrition from 1980 to 1994, an associate professor of gerontology from 1994 to 2000, and a full professor of internal medicine since 2000. Moreover, he is the Director of the O.U. Internal Medicine for Vascular Disease Prevention. He was a Member of the European and International Atherosclerosis Societies and of the National Executive Board of the Italian Atherosclerosis Society from 1995 to 2007, and he is a Member of the International MED PED FH Council since 1992. In addition, he is a Reviewer of papers submitted to Aging, American Journal of Human Genetics, American Journal of Medical Genetics, Americal Journal of Cardiovascular Drugs, Arteriosclerosis Thrombosis and Vascular Biology, Atherosclerosis, Biochimica et Biophysica Acta, Clinical Genetics, Clinical Lipidology, European Journal of Human Genetics, European Journal of Clinical Investigation, FORUM Trends in Experimental and Clinical Medicine, Human Mutation, Journal of Endocrinologial Investigation, Nutrition Metabolism and Cardiovascular Diseases, Pharmacological Research, Thrombosis and Haemostasis, and Translational Research. His scientific activity focuses on molecular genetics of dyslipidemias: hypercholesterolemia (codominant: LDL-R, APOB, PCSK9 genes; recessive: ARH, ABCG5/G8 genes), CESD (LIPA gene), hypoalphalipoproteinemias (ABCA1, APOAI, LCAT, GBA, LPL genes), hyperchylomicronemia (LPL, APOC2, APOA5 genes), hypobetalipoproteinemias (APOB, MTP, PCSK9 genes), dysbetalipoproteinemia (APOE gene), cerebrotendinous xanthomatosis (CYP27 gene), and poligenic hyperchol (variants of APOE, APOB, NPC1L1, PCSK9). His scientific publications include 124 international full papers, 150 national full papers, 148 international abstracts, 174 national abstracts, and 2073 citations.
Biography Updated on 24 June 2009